Warning: The NCBI web site requires JavaScript to function. more...
Bench-to-bedside review: Candida infections in the intensive care unit.
Méan M, Marchetti O, Calandra T.
Crit Care. 2008;12(1):204. Epub 2008 Jan 22. Review.
Related citations
Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD, Lyseng-Williamson KA, Scott LJ.
Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.
Invasive fungal infections: the challenge continues.
Gullo A.
Drugs. 2009;69 Suppl 1:65-73. doi: 10.2165/11315530-000000000-00000. Review.
Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
Lichtenstern C, Nguyen TH, Schemmer P, Hoppe-Tichy T, Weigand MA.
Mycoses. 2008;51 Suppl 1:35-46. Review.
New options for treatment of candidaemia in critically ill patients.
Ruhnke M, Hartwig K, Kofla G.
Clin Microbiol Infect. 2008 May;14 Suppl 4:46-54. Review.
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O; AmarCand Study Group.
Crit Care Med. 2009 May;37(5):1612-8.
Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG, Dralle H.
Eur J Med Res. 2002 May 31;7(5):200-26. Review.
Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
Cross SA, Scott LJ.
Drugs. 2008;68(15):2225-55. Review.
Patients at high risk of invasive fungal infections: when and how to treat.
Rüping MJ, Vehreschild JJ, Cornely OA.
Drugs. 2008;68(14):1941-62. Review.
[Echinocandins in invasive candidiasis].
Glöckner A, Cornely OA.
Med Klin (Munich). 2008 Jun 15;103(6):397-405. Review. German.
Invasive candidiasis in the intensive care unit.
Ostrosky-Zeichner L, Pappas PG.
Crit Care Med. 2006 Mar;34(3):857-63. Review.
[Role of anidulafungin in critically ill patients].
Borges Sá M, Garnacho Montero J.
Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 14:35-43. Review. Spanish.
Epidemiology and outcome of Candida bloodstream infection in an intensive care unit in Hong Kong.
Yap HY, Kwok KM, Gomersall CD, Fung SC, Lam TC, Leung PN, Hui M, Joynt GM.
Hong Kong Med J. 2009 Aug;15(4):255-61.
Echinocandins: role in antifungal therapy, 2005.
Zaas AK, Alexander BD.
Expert Opin Pharmacother. 2005 Aug;6(10):1657-68. Review.
Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M.
Int J Antimicrob Agents. 2011 Jul;38(1):65-9. Epub 2011 Apr 22.
[Therapy of candidemia and invasive candidiasis according to guidelines].
Glöckner A.
Mycoses. 2010 May;53 Suppl 1:30-5. Review. German.
Treatment of invasive candidiasis with echinocandins.
Glöckner A, Steinbach A, Vehreschild JJ, Cornely OA.
Mycoses. 2009 Nov;52(6):476-86. Review.
Management of invasive candidiasis in critically ill patients.
Blot S, Vandewoude K.
Drugs. 2004;64(19):2159-75. Review.
Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
Hsueh PR, Graybill JR, Playford EG, Watcharananan SP, Oh MD, Ja'alam K, Huang S, Nangia V, Kurup A, Padiglione AA.
Int J Antimicrob Agents. 2009 Sep;34(3):205-9. Epub 2009 May 5.
Caspofungin therapy of neonates with invasive candidiasis.
Odio CM, Araya R, Pinto LE, Castro CE, Vasquez S, Alfaro B, Sàenz A, Herrera ML, Walsh TJ.
Pediatr Infect Dis J. 2004 Dec;23(12):1093-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on